RK

Ravi Kiran Garikapati

Director Director DIN 08289990
DIN 08289990 First appointment Dec 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2018
Shareholding value •••• Premium profile

About Ravi Kiran Garikapati

Data last updated:

Ravi Kiran Garikapati was a Director at Arni Medica Private Limited (2019–2024) and Director at Stark Pharma Private Limited (2018–2022). The companies operate in Healthcare and Business Outsourcing.

DIN 08289990
Primary Designation Director
Industry Healthcare
First Appointment 01 Dec 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arni Medica Private Limited U33309TG2019PTC137891
Director24 Dec 20192019₹5.37 Cr (FY 2025)Active
Stark Pharma Private Limited U72900TG2014PTC097007
Director01 Dec 20182014₹1.43 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arni Medica Private Limited
Stark Pharma Private Limited
Premium access

Shareholding and investment profile for Ravi Kiran Garikapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Kiran Garikapati

Ravi Kiran Garikapati was first appointed on 01 Dec 2018 as Director at Stark Pharma Private Limited. The most recent appointment on record is 24 Dec 2019 at Arni Medica Private Limited.

Ravi Kiran Garikapati held 2 earlier board appointments: Arni Medica Private Limited (Director, 24 Dec 2019 to 08 Apr 2024); Stark Pharma Private Limited (Director, 01 Dec 2018 to 30 Nov 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available